Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry | Zendy

Bradley A. Bart | Zendy; Georg Ertl | Zendy; Peter Held | Zendy; J Kuch | Zendy; Aldo P. Maggioni | Zendy; John J.V. McMurray | Zendy; Eric L. Michelson | Zendy; J. L. Rouleau | Zendy; Lynne W. Stevenson | Zendy; Karl Swedberg | Zendy; James B. Young | Zendy; Salim Yusuf | Zendy; Mary Ann Sellers | Zendy; C. B. Granger | Zendy; Robert M. Califf | Zendy; M.A. Pfeffer for the SPICE investigators | Zendy

Open Access

Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry

Author(s) -

Bradley A. Bart,

Georg Ertl,

Peter Held,

J Kuch,

Aldo P. Maggioni,

John J.V. McMurray,

Eric L. Michelson,

J. L. Rouleau,

Lynne W. Stevenson,

Karl Swedberg,

James B. Young,

Salim Yusuf,

Mary Ann Sellers,

C. B. Granger,

Robert M. Califf,

M.A. Pfeffer for the SPICE investigators

Publication year - 1999

Publication title -

european heart journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.336

H-Index - 293

eISSN - 1522-9645

pISSN - 0195-668X

DOI - 10.1053/euhj.1998.1481

Subject(s) - medicine , ejection fraction , demographics , heart failure , angiotensin converting enzyme , ace inhibitor , cardiology , blood pressure , demography , sociology

The reported prevalence of angiotensin-converting enzyme (ACE) inhibitor use in patients with heart failure varies considerably. Recent reports suggest that many patients who could benefit from such therapy are not receiving ACE inhibitors. The Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry was established to understand better the demographics, characteristics, and contemporary use of ACE inhibitors in an international registry.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research